Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme

  • Silvio Danese
  • , Axel Dignass
  • , Katsuyoshi Matsuoka
  • , Marc Ferrante
  • , Millie Long
  • , Isabel Redondo
  • , Richard Moses
  • , Sebastian Maier
  • , Theresa Hunter Gibble
  • , Nathan Morris
  • , Catherine Milch
  • , Maria T. Abreu

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Neuroscience